Michael Sassano

    CEO
    SOMAÍ Pharmaceuticals

    Michael Sassano, CEO of SOMAÍ Pharmaceuticals

    Michael Sassano was an early investor in the United States cannabis industry and now heads SOMAÍ Pharmaceuticals, a next-generation biotech company centred on the cultivation, manufacturing, and distribution of GMP-certified cannabinoid-containing pharmaceutical products throughout the European Union. SOMAÍ opened Europe’s largest cannabis manufacturing facility earlier this year in Lisbon, Portugal.